BEAM™ establishes a new standard in personalized brain health care by seamlessly merging EEG technology with automated neurocognitive tests to derive precise biomarkers. This cutting-edge biomarker technology, paired with comprehensive analytics, offers a nuanced understanding of neurodegenerative and psychiatric disorders. It facilitates differentiation of dementia sub-types, quantifies cognitive decline severity, monitors disease progression, and evaluates treatment efficacy. The holistic BEAM™ approach places it at the forefront of brain health innovation, delivering precise and personalized diagnostic solutions for brain health.